Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
13 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$3.01
Price-2.90%
-$0.09
1Y
Price
Market Cap
$249.363m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$49.815m
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$74.459m
-
1y CAGR-
3y CAGR-
5y CAGREPS
-$0.99
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$49.629m
$128.887m
Assets$79.258m
Liabilities$59.497m
DebtDebt to Assets
46.2%
-0.9x
Debt to EBITDAFree Cash Flow
-$59.850m
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company